MONT-SAINT-GUIBERT, Belgium, October 7, 2013 /PRNewswire/ --
The Belgian biotechnology company Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative, protective and reconstructive therapies for the treatment of cardiac diseases, announces the......
More...
